{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T13:56:40Z","timestamp":1715003800706},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,20]]},"DOI":"10.7759\/cureus.36434","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T23:35:13Z","timestamp":1679355313000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Polymyositis and Systemic Sclerosis Overlap Syndrome: Diagnosis and Treatment"],"prefix":"10.7759","author":[{"given":"Mohammad K","family":"Uddin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopeessh","family":"Vempati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sravani","family":"Bhavanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praver Chandan C","family":"Parven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinmay","family":"Khotele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja H","family":"Chitturi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anagha","family":"Shree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smaran","family":"Kasireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01451046","article-title":"Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD","volume":"17","author":"Danieli MG","year":"1998","unstructured":"Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G. Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol. 1998, 17:195-201. 10.1007\/BF01451046","journal-title":"Clin Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1422.029","article-title":"Systemic sclerosis-associated myopathy","volume":"1108","author":"Ranque B","year":"2007","unstructured":"Ranque B, Authier FJ, Berezne A, Guillevin L, Mouthon L. Systemic sclerosis-associated myopathy. Ann NY Acad Sci. 2007, 1108:268-82. 10.1196\/annals.1422.029","journal-title":"Ann NY Acad Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/ar4562","article-title":"Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology","volume":"16","author":"Bhansing KJ","year":"2014","unstructured":"Bhansing KJ, Lammens M, Knaapen HK, van Riel PL, van Engelen BG, Vonk MC. Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology. Arthritis Res Ther. 2014, 16:111. 10.1186\/ar4562","journal-title":"Arthritis Res Ther"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.4103\/CDR.CDR_44_18","article-title":"Systemic lupus erythematosus and overlap: a clinician perspective","volume":"3","author":"Shah S","year":"2019","unstructured":"Shah S, Chengappa K, Negi V. Systemic lupus erythematosus and overlap: a clinician perspective. Clin Dermatol Rev . 2019, 3:12-7.","journal-title":"Clin Dermatol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen F","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, et al.. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013, 72:1747-55. 10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-004-0975-7","article-title":"Clinical and laboratory features of scleroderma patients developing skeletal myopathy","volume":"24","author":"Mimura Y","year":"2005","unstructured":"Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol. 2005, 24:99-102. 10.1007\/s10067-004-0975-7","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(93)90075-k","article-title":"Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association","volume":"125","author":"Follansbee WP","year":"1993","unstructured":"Follansbee WP, Zerbe TR, and Medsger Jr. TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J. 1993, 125:194-203. 10.1016\/0002-8703(93)90075-k","journal-title":"Am Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova SI","year":"2020","unstructured":"Nihtyanova SI, Sari A, Harvey JC, et al.. Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis. Arthritis Rheumatol. 2020, 72:465-76. 10.1002\/art.41153","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rky002","article-title":"Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis","volume":"2","author":"Caetano J","year":"2018","unstructured":"Caetano J, Nihtyanova SI, Harvey J, Denton CP, Ong VH. Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis. Rheumatol Adv Pract. 2018, 2:rky002. 10.1093\/rap\/rky002","journal-title":"Rheumatol Adv Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270202","article-title":"Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis","volume":"27","author":"Steen VD","year":"1984","unstructured":"Steen VD, Ziegler GL, Rodnan GP, Medsger TA Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984, 27:125-31. 10.1002\/art.1780270202","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.025","article-title":"Pulmonary involvement in systemic sclerosis","volume":"15","author":"Morales-C\u00e1rdenas A","year":"2016","unstructured":"Morales-C\u00e1rdenas A, P\u00e9rez-Madrid C, Arias L, et al.. Pulmonary involvement in systemic sclerosis. Autoimmun Rev. 2016, 15:1094-108. 10.1016\/j.autrev.2016.07.025","journal-title":"Autoimmun Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.06.010","article-title":"Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies","volume":"7","author":"Koenig M","year":"2008","unstructured":"Koenig M, Dieud\u00e9 M, Sen\u00e9cal JL. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Autoimmun Rev. 2008, 7:588-93. 10.1016\/j.autrev.2008.06.010","journal-title":"Autoimmun Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen VD","year":"2005","unstructured":"Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005, 35:35-42. 10.1016\/j.semarthrit.2005.03.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","author":"Pope JE","year":"2023","unstructured":"Pope JE, Denton CP, Johnson SR, Fernandez-Codina A, Hudson M, Nevskaya T. State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol. 2023, 1-15. 10.1038\/s41584-023-00909-5","journal-title":"Nat Rev Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxy283","article-title":"Revisiting dietary iron requirement and deficiency in Indian women: implications for food iron fortification and supplementation","volume":"149","author":"Ghosh S","year":"2019","unstructured":"Ghosh S, Sinha S, Thomas T, Sachdev HS, Kurpad AV. Revisiting dietary iron requirement and deficiency in Indian women: implications for food iron fortification and supplementation. J Nutr. 2019, 149:366-71. 10.1093\/jn\/nxy283","journal-title":"J Nutr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-006-0480-8","article-title":"A case of systemic sclerosis complicated by autoimmune hemolytic anemia","volume":"16","author":"Katsumata K","year":"2006","unstructured":"Katsumata K. A case of systemic sclerosis complicated by autoimmune hemolytic anemia. Mod Rheumatol. 2006, 16:191-5. 10.1007\/s10165-006-0480-8","journal-title":"Mod Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175013","article-title":"Anemia is an indicator for worse organ damage trajectories in patients with systemic sclerosis: a retrospective study","volume":"11","author":"Li Z","year":"2022","unstructured":"Li Z, Xu D, Jiang X, Li T, Su Y, Mu R. Anemia is an indicator for worse organ damage trajectories in patients with systemic sclerosis: a retrospective study. J Clin Med. 2022, 11:5013. 10.3390\/jcm11175013","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00266","article-title":"Associations between systemic sclerosis and thyroid diseases","volume":"8","author":"Fallahi P","year":"2017","unstructured":"Fallahi P, Ruffilli I, Giuggioli D, Colaci M, Ferrari SM, Antonelli A, Ferri C. Associations between systemic sclerosis and thyroid diseases. Front Endocrinol (Lausanne). 2017, 8:266. 10.3389\/fendo.2017.00266","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.921260","article-title":"Regulatory B cells in systemic sclerosis isolated or concomitant with Hashimoto thyroiditis","volume":"13","author":"Capriello S","year":"2022","unstructured":"Capriello S, Ferrari SM, Gatto I, et al.. Regulatory B cells in systemic sclerosis isolated or concomitant with Hashimoto thyroiditis. Front Immunol. 2022, 13:921260. 10.3389\/fimmu.2022.921260","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1467-y","article-title":"Systemic sclerosis medications and risk of scleroderma renal crisis","volume":"20","author":"Gordon SM","year":"2019","unstructured":"Gordon SM, Hughes JB, Nee R, et al.. Systemic sclerosis medications and risk of scleroderma renal crisis. BMC Nephrol. 2019, 20:279. 10.1186\/s12882-019-1467-y","journal-title":"BMC Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew224","article-title":"BSR and BHPR guideline for the treatment of systemic sclerosis","volume":"55","author":"Denton CP","year":"2016","unstructured":"Denton CP, Hughes M, Gak N, et al.. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology (Oxford). 2016, 55:1906-10. 10.1093\/rheumatology\/kew224","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/144319-a-rare-case-of-polymyositis-and-systemic-sclerosis-overlap-syndrome-diagnosis-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:48Z","timestamp":1707508668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/144319-a-rare-case-of-polymyositis-and-systemic-sclerosis-overlap-syndrome-diagnosis-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.36434","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}